Identity
- Security key
- 12379
- Ticker
- BDSX
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2020-10-28
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- BDSX
Detail
Enriched 2026-08-14 20:47
- Market cap
- $255,548,077.96
- Shares outstanding (class)
- 10,551,118
- Shares outstanding (weighted)
- 10,551,118
- SIC
- 8071 SERVICES-MEDICAL LABORATORIES
- Employees
- 334
- Location
- LOUISVILLE, CO
- Homepage
- https://www.biodesix.com
- Description
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.